PPD Development, L.P.

FDA 483 - PPD Development, L.P.

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore PPD Development, L.P.

Record Details

An FDA inspection of PPD Development LLC in Middleton, WI, a Contract Research Organization (CRO), identified a data integrity issue related to the reporting of analytical results. The firm reported results for next generation impactor (NGI) data that were below the established limits of quantification (LOQs), indicating potential inaccuracies in their analytical methods or reporting practices. This observation suggests a moderate severity issue concerning data reliability in their in-vitro bioequivalence studies.

Company: PPD Development, L.P.
Product Type: Drugs
Office: Minneapolis District Office
People: Denise L. Burosh (Bioresearch Monitoring Specialis)
Makini Cobourne-Duval (other)
Himanshu Gupta (issuing_officer)

Open in Dashboard

ID · 61346431-fa4f-4c39-9544-0c075a540d6b